Syncromune, Inc.
Fort Lauderdale · Broward CountySEC filing ↗
Syncromune, Inc. is a biotechnology company in Fort Lauderdale, Florida that filed a Form D with the SEC, reporting $145M sold to 77 investors. Latest filing May 11, 2026.
Reported sold
$145M
Offering size
$145M100% sold
Investors on filing
77
SEC industry
Biotechnology
First filing
May 11, 2026
Latest filing
May 11, 2026
Filings on record
1
Officers & directors on the filing
as reported to the SEC at filing time — not investors- Joseph J. GerardiExecutive Officer
- Jeffrey L. ClelandDirector
- Douglas G. WatsonDirector
- Joseph C. MaroonDirector
- Stephen L. DaleExecutive Officer
- Norman L. SchwartzDirector
- Charles J. LinkExecutive OfficerDirector
- Eamonn J. HobbsExecutive OfficerDirector
Form D lists a company's executive officers, directors and promoters at the time of the offering. It does not name who invested. Amounts are what the issuer reported sold under Regulation D — not a valuation.
South Florida firms that invest in this space
BiotechnologyOther companies in Broward County
- SKYX Platforms Corp.$25MPompano Beach · Other Technology
- Hyperion Surgical, Inc.$13MWeston · Other Technology
- BioStem Technologies, Inc.$2.5MPompano Beach · Biotechnology
- Spaxial Interactive, Inc.$2.5MFort Lauderdale · Other Technology
- CarePredict, Inc.$2MPlantation · Other Technology
- Kaida BioPharma Inc.$1.6MFort Lauderdale · Biotechnology